SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Friday 30 October 2026
News from the 24 hours to Friday morning, 30 October 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was built around a single article asking whether Smith & Nephew can turn around its underperforming US implant unit. It leans slightly negative because it points to a problem area with no resolution.
What drove it
- US implant weakness
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Sat 24 Oct | −5.7 | 21 |
| Sun 25 Oct | −2.0 | 3 |
| Mon 26 Oct | −1.2 | 4 |
| Tue 27 Oct | −5.3 | 4 |
| Wed 28 Oct | +7.0 | 1 |
| Thu 29 Oct | −5.8 | 1 |
| Fri 30 Oct | −4.7 | 1 |
1 story · 1 headline · strongest first
Pharma and healthcare on 30 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew faces weak US implant sales −5.21 headline today · 2 in all, since 29 October · An article questions whether Smith & Nephew is able to turn around its underperforming US implants unit. | ||
| −4.7 | Questions whether the firm can repair a struggling American implant division. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.